Abstract
Long conserved mechanisms maintain homeostasis in living creatures in response to a variety of stresses. However, continuous exposure to stress can result in unabated production of stress hormones, especially catecholamines, which can have detrimental health effects. While the long-term effects of chronic stress have well-known physiological consequences, recent discoveries have revealed that stress may affect therapeutic efficacy in cancer. Growing epidemiological evidence reveals strong correlations between progression-free and long-term survival and β-blocker usage in cancer patients. In this review, we summarize the current understanding of how the catecholamines, epinephrine and norepinephrine, affect cancer cell survival and tumor progression. We also highlight new data exploring the potential contributions of stress to immunosuppression in the tumor microenvironment and the implications of these findings for the efficacy of immunotherapies.
Original language | English (US) |
---|---|
Pages (from-to) | 1115-1128 |
Number of pages | 14 |
Journal | Cancer Immunology, Immunotherapy |
Volume | 63 |
Issue number | 11 |
DOIs | |
State | Published - Oct 25 2014 |
Keywords
- Catecholamines
- Immunosuppression
- Immunotherapies
- Nervous system
- Stress
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology
- Cancer Research